From the Laboratory to the Clinic: Developing Novel Therapeutic Approaches

From Laboratory to Clinic is an annual translational research conference established in 1984. It is organised by an international committee led by past and present Directors of the Kennedy Institute, Profs Sir Marc Feldmann, Sir Ravinder Maini and Fiona Powrie. The meeting brings together basic scientists, clinicians, and industry researchers to explore how the latest discoveries in immunology and molecular medicine can be applied to improve clinical medicine.

TOPICS

• Covid
• Aging
• Cell Therapy
• Drug Delivery
• Neuroinflammation and Neurodegeneration
• Progress in Major Diseases 

CONFIRMED SPEAKERS

• Cameron Alexander, University of Nottingham
• Christian Buchholz, Paul-Ehrlich-Institut
• Jean-Laurent Casanova, Rockefeller University
• Mark Davis, Stanford University, USA 
• Avi Domb, The Hebrew University 
• Lars Fugger, University of Oxford 
• Stephen Holgate, University of Southampton 
• James Kirkland, Mayo Clinic 
• Lotte Bjerre Knudsen, Novo Nordisk 
• Michelle Linterman, Babraham Instititute, Cambridge 
• Ira Mellman, Genentech 
• Ulrike Müller, University of Heidelberg 
• Mike Murphy, MRC Mitochondrial Biology Unit, University of Cambridge 
• Linda Partridge, University College London and Max Planck Institute 
• Marion Pepper, University of Washington 
• Gregory Petsko, Brigham and Women’s Hospital, Harvard 
• Marco Prinz, University of Freiburg                   
• Francisco Quintana, Harvard Medical School 
• Jeff Ravetch, The Rockefeller University 
• Vladik Sandler, Hemogenyx 
• Georg Schett, FAU, Erlangen 
• Mikhail Shchepinov, BioJiva (formerly Retrotope) 
• Ashok Venkitaraman, Cancer Science Institute, Singapore